CURRENT AFFAIRS
CURRENT AFFAIRS
Description
The Union Minister Dr. Jitendra Singh recently announced the launch of Nafithromycin, a groundbreaking antibiotic designed to combat Antimicrobial Resistance (AMR), particularly focusing on Community-Acquired Bacterial Pneumonia (CABP). This new development marks a significant step forward in biotechnology advancements in India.
Development Background
Nafithromycin is the first antibiotic developed in India specifically targeting AMR. It was created with support from the Biotechnology Industry Research Assistance Council (BIRAC) and is manufactured by Wockhardt under the brand name Miqnaf. The antibiotic’s development spanned 14 years of research, with an investment of Rupees 500 crores.
Importance Of Nafithromycin
This antibiotic addresses a major global health crisis. Pneumonia caused by drug-resistant bacteria leads to over two million deaths each year, with India accounting for 23% of global cases of community-acquired pneumonia. Traditional treatments, like azithromycin, have become less effective due to increasing resistance. Nafithromycin, however, is ten times more potent than current treatments. It offers a quicker, safer, and more tolerable treatment option for patients, with a three-day treatment regimen that has shown fewer side effects, including minimal stomach issues and no dietary restrictions.
Awaiting Regulatory Approval
Nafithromycin is currently awaiting final approval from India’s Central Drugs Standard Control Organization (CDSCO). Once approved, the drug will be manufactured and made available to the public.
Addressing The AMR Challenge
Dr. Jitendra Singh emphasized the urgency of tackling Antimicrobial Resistance (AMR), noting how the COVID-19 pandemic heightened awareness about the potential of biotechnology. He urged continued innovation in AMR research and called for greater collaboration among governments, pharmaceutical companies, and research institutions to address this growing threat to public health.
The Role Of Public-Private Collaboration
The launch of Nafithromycin highlights India's expanding capabilities in biotechnology and healthcare solutions. Dr. Singh lauded the collaboration between public and private sectors as a critical driver of innovation. He expressed hope that this breakthrough would pave the way for future advancements in life-saving medicines, reinforcing India’s position as a leader in the global fight against antimicrobial resistance.
Welcome to Notopedia.com, your free learning platform that caters to the diverse needs of students and aspirants across a spectrum of entrance exams and educational endeavors. Whether you're preparing for highly anticipated exams like CAT 2023, NEET 2023, JEE Main, or bank job vacancies, our platform offers a wealth of resources to guide you towards success. Stay up-to-date with the latest exam dates, announcements, and results for various government recruitment exams, including SSC CGL, CHSL, NDA, and UPSC. Explore comprehensive study materials, sample papers, and exam patterns to hone your skills and boost your confidence. From important dates like CBSE Class 10 and 12 date sheets to exam-specific information like JEE Main 2023 application form date, we cover it all. Notopedia.com is your go-to source for everything from admissions and admit cards to scholarships and college information. Whether you're aiming for a career in defense, government, banking, or higher education, our free learning platform equips you with the knowledge and resources you need to excel. Join us in your educational journey and unlock a world of opportunities, guidance, and comprehensive support.
For more Updates and Information - Visit Notopedia's Bulletin Board
For Latest Sarkari Jobs - Visit Notopedia's Sarkari Jobs Section
For access to more than 20,000 Colleges - Visit Notopedia's College Section
For School Studies and Exams Preparation across 14 Boards - Visit Notopedia's School Section
For Comprehensive Preparation of Sarkari Job Exams - Visit Notopedia's Sarkari Exams Section
